Activated FOXO-mediated insulin resistance is blocked by reduction of TOR activity

Cell Metabolism

Volumn 4, Issue 2, 2006, Pages 133-142

  Luong, Nancy ^a   Davies, Claire R ^a   Wessells, Robert J ^a   Graham, Suzanne M ^a   King, M Todd ^b   Veech, Richard ^b   Bodmer, Rolf ^a   Oldham, Sean M ^a  

^a BURNHAM INSTITUTE   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

HUMDISEASE; SIGNALING

Indexed keywords

INSULIN; TARGET OF RAPAMYCIN KINASE; TRANSCRIPTION FACTOR FOXO;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DROSOPHILA; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HEART DISEASE; INSULIN RESISTANCE; LIPID STORAGE; LONGEVITY; METABOLIC REGULATION; METABOLIC SYNDROME X; MOLECULAR EVOLUTION; NONHUMAN; PHENOTYPE; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; SENESCENCE; SYSTEMS BIOLOGY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ALLELES; AMINO ACID SEQUENCE; ANIMALS; DOWN-REGULATION; DROSOPHILA; DROSOPHILA PROTEINS; FORKHEAD TRANSCRIPTION FACTORS; GLUCOSE; INSULIN RESISTANCE; LIPIDS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN KINASES; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 33746564095     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2006.05.013     Document Type: Article

References (93)

1. Abraham R.T. Identification of TOR signaling complexes: more TORC for the cell growth engine. Cell 111 (2002) 9-12
2. Accili D., and Arden K.C. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117 (2004) 421-426
3. Araki E., Lipes M.A., Patti M.E., Bruning J.C., Haag III B., Johnson R.S., and Kahn C.R. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372 (1994) 186-190
4. Barthel A., Schmoll D., and Unterman T.G. FoxO proteins in insulin action and metabolism. Trends Endocrinol. Metab. 16 (2005) 183-189
5. Belke D.D., Betuing S., Tuttle M.J., Graveleau C., Young M.E., Pham M., Zhang D., Cooksey R.C., McClain D.A., Litwin S.E., et al. Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J. Clin. Invest. 109 (2002) 629-639
6. Bell E., Cao X., Moibi J.A., Greene S.R., Young R., Trucco M., Gao Z., Matschinsky F.M., Deng S., Markman J.F., et al. Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets. Diabetes 52 (2003) 2731-2739
7. Bernal A., and Kimbrell D.A. Drosophila Thor participates in host immune defense and connects a translational regulator with innate immunity. Proc. Natl. Acad. Sci. USA 97 (2000) 6019-6024
8. Biddinger S.B., and Kahn C.R. From Mice to Men: Insights into the insulin resistance syndromes. Annu. Rev. Physiol. 68 (2006) 1-36
9. Böhni R., Riesgo-Escovar J., Oldham S., Brogiolo W., Stocker H., Andruss B.F., Beckingham K., and Hafen E. Autonomous control of cell and organ size by CHICO, a Drosophila homolog of vertebrate IRS1-4. Cell 97 (1999) 865-875
10. Bolster D.R., Crozier S.J., Kimball S.R., and Jefferson L.S. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J. Biol. Chem. 277 (2002) 23977-23980
11. Brogiolo W., Stocker H., Ikeya T., Rintelen F., Fernandez R., and Hafen E. An evolutionarily conserved function of the Drosophila insulin receptor and insulin-like peptides in growth control. Curr. Biol. 11 (2001) 213-221
12. Broughton S.J., Piper M.D., Ikeya T., Bass T.M., Jacobson J., Driege Y., Martinez P., Hafen E., Withers D.J., Leevers S.J., and Partridge L. Longer lifespan, altered metabolism, and stress resistance in Drosophila from ablation of cells making insulin-like ligands. Proc. Natl. Acad. Sci. USA 102 (2005) 3105-3110
13. Burgering B.M., and Kops G.J. Cell cycle and death control: long live Forkheads. Trends Biochem. Sci. 27 (2002) 352-360
14. Burks D.J., de Mora J.F., Schubert M., Withers D.J., Myers M.G., Towery H.H., Altamuro S.L., Flint C.L., and White M.F. IRS-2 pathways integrate female reproduction and energy homeostasis. Nature 407 (2000) 377-382
15. Burks D.J., and White M.F. IRS proteins and β-cell function. Diabetes 50 Suppl 1 (2001) S140-S145
16. Cahill Jr. G.F., and Veech R.L. Ketoacids? Good medicine?. Trans. Am. Clin. Climatol. Assoc. 114 (2003) 149-161
17. Carling D. The AMP-activated protein kinase cascade-a unifying system for energy control. Trends Biochem. Sci. 29 (2004) 18-24
18. Carlson C.J., White M.F., and Rondinone C.M. Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation. Biochem. Biophys. Res. Commun. 316 (2004) 533-539
19. Chiu H.C., Kovacs A., Blanton R.M., Han X., Courtois M., Weinheimer C.J., Yamada K.A., Brunet S., Xu H., Nerbonne J.M., et al. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. Circ. Res. 96 (2005) 225-233
20. Fly Consortium. FlyBase - the Drosophila database. Nucleic Acids Res. 22 (1994) 3456-3458
21. Curtis R., Geesaman B.J., and DiStefano P.S. Ageing and metabolism: drug discovery opportunities. Nat. Rev. Drug Discov. 4 (2005) 569-580
22. Dubbelhuis P.F., and Meijer A.J. Hepatic amino acid-dependent signaling is under the control of AMP-dependent protein kinase. FEBS Lett. 521 (2002) 39-42
23. Finch C.E., and Ruvkun G. The genetics of aging. Annu. Rev. Genomics Hum. Genet. 2 (2001) 435-462
24. Fingar D.C., and Blenis J. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 23 (2004) 3151-3171
25. Giannakou M.E., Goss M., Junger M.A., Hafen E., Leevers S.J., and Partridge L. Long-lived Drosophila with overexpressed dFOXO in adult fat body. Science 305 (2004) 361
26. Giraud J., Leshan R., Lee Y.H., and White M.F. Nutrient-dependent and insulin-stimulated phosphorylation of insulin receptor substrate-1 on serine 302 correlates with increased insulin signaling. J. Biol. Chem. 279 (2004) 3447-3454
27. Greer E.L., and Brunet A. FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24 (2005) 7410-7425
28. Grönke S., Mildner A., Fellert S., Tennagels N., Petry S., Müller G., Jäckle H., and Kühnlein R.P. Brummer lipase is an evolutionary conserved fat storage regulator in Drosophila. Cell Metab. 1 (2005) 323-330
29. Hara K., Maruki Y., Long X., Yoshino K., Oshiro N., Hidayat S., Tokunaga C., Avruch J., and Yonezawa K. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110 (2002) 177-189
30. Hardie D.G. New roles for the LKB1→AMPK pathway. Curr. Opin. Cell Biol. 17 (2005) 167-173
31. Haruta T., Uno T., Kawahara J., Takano A., Egawa K., Sharma P.M., Olefsky J.M., and Kobayashi M. A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1. Mol. Endocrinol. 14 (2000) 783-794
32. Hwangbo D.S., Gershman B., Tu M.P., Palmer M., and Tatar M. Drosophila dFOXO controls lifespan and regulates insulin signalling in brain and fat body. Nature 429 (2004) 562-566
33. Ikeya T., Galic M., Belawat P., Nairz K., and Hafen E. Nutrient-dependent expression of insulin-like peptides from neuroendocrine cells in the CNS contributes to growth regulation in Drosophila. Curr. Biol. 12 (2002) 1293-1300
34. Inoki K., Zhu T., and Guan K.L. TSC2 mediates cellular energy response to control cell growth and survival. Cell 115 (2003) 577-590
35. Jakobsen S.N., Hardie D.G., Morrice N., and Tornqvist H.E. 5′-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside. J. Biol. Chem. 276 (2001) 46912-46916
36. Jia K., Chen D., and Riddle D.L. The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span. Development 131 (2004) 3897-3906
37. Jünger M.A., Rintelen F., Stocker H., Wasserman J.D., Vegh M., Radimerski T., Greenberg M.E., and Hafen E. The Drosophila Forkhead transcription factor FOXO mediates the reduction in cell number associated with reduced insulin signaling. J. Biol. 2 (2003) 20-36
38. Kaeberlein M., Powers III R.W., Steffen K.K., Westman E.A., Hu D., Dang N., Kerr E.O., Kirkland K.T., Fields S., and Kennedy B.K. Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science 310 (2005) 1193-1196
39. Kahn B.B., Alquier T., Carling D., and Hardie D.G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 1 (2005) 15-25
40. Kapahi P., Zid B.M., Harper T., Koslover D., Sapin V., and Benzer S. Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway. Curr. Biol. 14 (2004) 885-890
41. Kenyon C. The plasticity of aging: insights from long-lived mutants. Cell 120 (2005) 449-460
42. Kenyon C., Chang J., Gensch E., Rudner A., and Tabtiang R. A C. elegans mutant that lives twice as long as wild type. Nature 366 (1993) 461-464
43. Kim D.H., and Sabatini D.M. Raptor and mTOR: subunits of a nutrient-sensitive complex. Curr. Top. Microbiol. Immunol. 279 (2004) 259-270
44. Kimura K.D., Tissenbaum H.A., Liu Y., and Ruvkun G. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 277 (1997) 942-946
45. Kimura N., Tokunaga C., Dalal S., Richardson C., Yoshino K., Hara K., Kemp B.E., Witters L.A., Mimura O., and Yonezawa K. A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway. Genes Cells 8 (2003) 65-79
46. Kitamura T., Nakae J., Kitamura Y., Kido Y., Biggs III W.H., Wright C.V., White M.F., Arden K.C., and Accili D. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic β cell growth. J. Clin. Invest. 110 (2002) 1839-1847
47. Kozma S.C., and Thomas G. Regulation of cell size in growth, development and human disease: PI3K, PKB and S6K. Bioessays 24 (2002) 65-71
48. Kramer J.M., Davidge J.T., Lockyer J.M., and Staveley B.E. Expression of Drosophila FOXO regulates growth and can phenocopy starvation. BMC Dev. Biol. 3 (2003) 5-18
49. Kulkarni R.N., Bruning J.C., Winnay J.N., Postic C., Magnuson M.A., and Kahn C.R. Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96 (1999) 329-339
50. Kwon G., Marshall C.A., Pappan K.L., Remedi M.S., and McDaniel M.L. Signaling elements involved in the metabolic regulation of mTOR by nutrients, incretins, and growth factors in islets. Diabetes 53 Suppl 3 (2004) S225-S232
51. Lee S.S., Kennedy S., Tolonen A.C., and Ruvkun G. DAF-16 target genes that control C. elegans life-span and metabolism. Science 300 (2003) 644-647
52. Lee Y.H., and White M.F. Insulin receptor substrate proteins and diabetes. Arch. Pharm. Res. 27 (2004) 361-370
53. Libina N., Berman J.R., and Kenyon C. Tissue-specific activities of C. elegans DAF-16 in the regulation of lifespan. Cell 115 (2003) 489-502
54. Lin K., Dorman J.B., Rodan A., and Kenyon C. daf-16: An HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science 278 (1997) 1319-1322
55. Long X., Muller F., and Avruch J. TOR action in mammalian cells and in Caenorhabditis elegans. Curr. Top Microbiol. Immunol. 279 (2004) 115-138
56. Matsumoto M., and Accili D. All roads lead to FoxO. Cell Metab. 1 (2005) 215-216
57. McDaniel M.L., Marshall C.A., Pappan K.L., and Kwon G. Metabolic and autocrine regulation of the mammalian target of rapamycin by pancreatic β-cells. Diabetes 51 (2002) 2877-2885
58. McElwee J., Bubb K., and Thomas J.H. Transcriptional outputs of the Caenorhabditis elegans forkhead protein DAF-16. Aging Cell 2 (2003) 111-121
59. Miron M., Verdu J., Lachance P.E., Birnbaum M.J., Lasko P.F., and Sonenberg N. The translational inhibitor 4E-BP is an effector of PI(3)K/Akt signalling and cell growth in Drosophila. Nat. Cell Biol. 3 (2001) 596-601
60. Morrisett J.D., Abdel-Fattah G., and Kahan B.D. Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipients. Transplant. Proc. 35 (2003) 143S-150S
61. Murphy C.T., McCarroll S.A., Bargmann C.I., Fraser A., Kamath R.S., Ahringer J., Li H., and Kenyon C. Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 424 (2003) 277-283
62. Nakae J., Biggs III W.H., Kitamura T., Cavenee W.K., Wright C.V., Arden K.C., and Accili D. Regulation of insulin action and pancreatic β-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat. Genet. 32 (2002) 245-253
63. Ogg S., Paradis S., Gottlieb S., Patterson G.I., Lee L., Tissenbaum H.A., and Ruvkun G. The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389 (1997) 994-999
64. Oldham S., and Hafen E. Insulin/IGF and target of rapamycin signaling: a TOR de force in growth control. Trends Cell Biol. 13 (2003) 79-85
65. Oldham S., Montagne J., Radimerski T., Thomas G., and Hafen E. Genetic and biochemical characterization of dTOR, the Drosophila homolog of the target of rapamycin. Genes Dev. 14 (2000) 2689-2694
66. Park S.Y., Kim H.J., Wang S., Higashimori T., Dong J., Kim Y.J., Cline G., Li H., Prentki M., Shulman G.I., et al. Hormone-sensitive lipase knockout mice have increased hepatic insulin sensitivity and are protected from short-term diet-induced insulin resistance in skeletal muscle and heart. Am. J. Physiol. Endocrinol. Metab. 289 (2005) E30-E39
67. Partridge L., and Gems D. Mechanisms of ageing: public or private?. Nat. Rev. Genet. 3 (2002) 165-175
68. Patti M.E., Brambilla E., Luzi L., Landaker E.J., and Kahn C.R. Bidirectional modulation of insulin action by amino acids. J. Clin. Invest. 101 (1998) 1519-1529
69. Pende M., Kozma S.C., Jaquet M., Oorschot V., Burcelin R., Le Marchand-Brustel Y., Klumperman J., Thorens B., and Thomas G. Hypoinsulinaemia, glucose intolerance and diminished β-cell size in S6K1-deficient mice. Nature 408 (2000) 994-997
70. Powers III R.W., Kaeberlein M., Caldwell S.D., Kennedy B.K., and Fields S. Extension of chronological life span in yeast by decreased TOR pathway signaling. Genes Dev. 20 (2006) 174-184
71. Puig O., Marr M.T., Ruhf M.L., and Tjian R. Control of cell number by Drosophila FOXO: downstream and feedback regulation of the insulin receptor pathway. Genes Dev. 17 (2003) 2006-2020
72. Rulifson E.J., Kim S.K., and Nusse R. Ablation of insulin-producing neurons in flies: growth and diabetic phenotypes. Science 296 (2002) 1118-1120
73. Saltiel A.R., and Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414 (2001) 799-806
74. Sarbassov D.D., Guertin D.A., Ali S.M., and Sabatini D.M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307 (2005) 1098-1101
75. Sarbassov D.D., Ali S.M., Sengupta S., Sheen J.-H., Hsu P.P., Bagley A.F., Markhard A.L., and Sabatini D.M. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22 (2006) 159-168
76. Sharp Z.D., and Bartke A. Evidence for down-regulation of phosphoinositide 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR)-dependent translation regulatory signaling pathways in Ames dwarf mice. J. Gerontol. A Biol. Sci. Med. Sci. 60 (2005) 293-300
77. Shaw R.J., Bardeesy N., Manning B.D., Lopez L., Kosmatka M., DePinho R.A., and Cantley L.C. The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 6 (2004) 91-99
78. Spradling A.C., Stern D., Beaton A., Rhem E.J., Laverty T., Mozden N., Misra S., and Rubin G.M. The Berkeley Drosophila Genome Project gene disruption project: Single P-element insertions mutating 25% of vital Drosophila genes. Genetics 153 (1999) 135-177
79. Tatar M., Bartke A., and Antebi A. The endocrine regulation of aging by insulin-like signals. Science 299 (2003) 1346-1351
80. Teleman A.A., Chen Y.W., and Cohen S.M. 4E-BP functions as a metabolic brake used under stress conditions but not during normal growth. Genes Dev. 19 (2005) 1844-1848
81. Teleman A.A., Chen Y.W., and Cohen S.M. Drosophila Melted modulates FOXO and TOR activity. Dev. Cell 9 (2005) 271-281
82. Teleman A.A., and Cohen S.M. Drosophila lacking microRNA miR-278 are defective in energy homeostasis. Genes Dev. 20 (2006) 417-422
83. Tettweiler G., Miron M., Jenkins M., Sonenberg N., and Lasko P.F. Starvation and oxidative stress resistance in Drosophila are mediated through the eIF4E-binding protein, d4E-BP. Genes Dev. 19 (2005) 1840-1843
84. Tran H., Brunet A., Griffith E.C., and Greenberg M.E. The many forks in FOXO's road. Sci. STKE 2003 (2003) RE5
85. Tremblay F., Krebs M., Dombrowski L., Brehm A., Bernroider E., Roth E., Nowotny P., Waldhausl W., Marette A., and Roden M. Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability. Diabetes 54 (2005) 2674-2684
86. Tzatsos A., and Kandror K.V. Nutrients suppress PI3K/Akt signaling via raptor-dependent mTOR-mediated IRS1 phosphorylation. Mol. Cell. Biol. 26 (2006) 63-74
87. Ueno M., Carvalheira J.B., Tambascia R.C., Bezerra R.M., Amaral M.E., Carneiro E.M., Folli F., Franchini K.G., and Saad M.J. Regulation of insulin signalling by hyperinsulinaemia: role of IRS-1/2 serine phosphorylation and the mTOR/p70 S6K pathway. Diabetologia 48 (2005) 506-518
88. Um S.H., Frigerio F., Watanabe M., Picard F., Joaquin M., Sticker M., Fumagalli S., Allegrini P.R., Kozma S.C., Auwerx J., and Thomas G. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431 (2004) 200-205
89. Vellai T., Takacs-Vellai K., Zhang Y., Kovacs A.L., Orosz L., and Muller F. Genetics: influence of TOR kinase on lifespan in C. elegans. Nature 426 (2003) 620
90. Wessells R.J., Fitzgerald E., Cypser J.R., Tatar M., and Bodmer R. Insulin regulation of heart function in aging fruit flies. Nat. Genet. 36 (2004) 1275-1281
91. Wolkow C.A., Kimura K.D., Lee M.S., and Ruvkun G. Regulation of C. elegans life-span by insulinlike signaling in the nervous system. Science 290 (2000) 147-150
92. Wullschleger S., Loewith R., and Hall M. TOR signaling in growth and metabolism. Cell 124 (2006) 471-484
93. Zhang H., Stallock J.P., Ng J.C., Reinhard C., and Neufeld T.P. Regulation of cellular growth by the Drosophila target of rapamycin dTOR. Genes Dev. 14 (2000) 2712-2724